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Interactions between microorganisms and humans range
from a benign, even symbiotic collaboration to a form of
competition that may become fatal for the host. Symbiotic
indigenous microbiota colonize those regions of the human
body that are in contact with the external environment, such
as the skin, eyes, oral cavity, and gastrointestinal tract, in
addition to some parts of the respiratory, urinary, and repro-
ductive tracts. Despite the fact that humans are fully exposed
to a wide variety of microorganisms, only certain popula-
tions are able to permanently inhabit the available body
sites. In order for a microorganism to become established
and thus to colonize a particular site, the environment of that
site must satisfy the microorganism’s nutritional and physic-
ochemical requirements. In addition, the microorganism
must be able to withstand host defenses, including various
mechanical removing systems and the innate and acquired
immune systems, as well as competition from the resident
microbial community. At present, little is known about the
mechanisms that enable the survival and long-term host tol-
erance of indigenous microbial communities or why these
microorganisms do not elicit a damaging chronic inflamma-
tory response. The evolutionary dynamics of host–pathogen
interactions result in an ongoing process of natural selection
in which there is adaptation and counter-adaptation by the
two competing species. As pathogens develop new ways to
avoid host recognition or elimination, host defenses must
evolve in parallel to keep pace with them.
During the course of pathogen–host coevolution, there
have been several infectious diseases that have notably
shaped human history, especially those marked by the novel
entrance into a population of a previously unknown infec-
tious agent. Nonetheless, these opportunities seem to be lim-
ited since, among the millions of species of microorganisms
(30 million species have been estimated for prokaryotes),
only 1922 species of infectious agents have been recorded, of
which 632 are bacteria (no archaea is known to be pathogen-
ic), 499 helminths, 329 fungi, 145 protists, and 317 viruses
and prions. 
Evolutionary biology of bacterial and fungal pathogens
is a multi-authored book based on a meeting organized by
Fundación Lilly [www.fundacionlilly.com] in El Escorial,
Madrid, in November 2004. The editors, Fernando Baquero,
César Nombela, Gail H. Cassell, and José A. Gutiérrez-
Fuentes (director of Fundación Lilly), have collaborated to
produce an excellent textbook, introducing evolutionary
biology to clinical microbiologists, infectious disease spe-
cialists, and public health professionals. The contributions of
the invited authors have resulted in an impressive book of
six sections comprising 49 chapters that cover topics funda-
mental to understanding the evolution of microbial
pathogens. The book is preceded by a short Foreword by
Julian Davies, who once more corroborates the dictum of the
Spanish classical writer Baltasar Gracián: “Good, if it’s
short, twice as good”. 
Section I, “Evolutionary biology of microbial-host inter-
actions” (chaps. 1–11). Bacteria gain no advantage by mak-
ing their hosts ill and illness certainly confers few, if any
host benefits. Virulence is a consequence of bacteria being in
the wrong host, or at the wrong site in the right host. The
strategies employed by bacterial pathogens, the number and
nature of the virulence factors required to activate them, and
the regulatory systems that control virulence gene expres-
sion are the result of coevolution between bacteria and their
hosts. The emergence of a new “professional” pathogen (an
organism adapted for circulation within the host population
as a pathogen) from a non-pathogen is a relatively rare
event, because it requires the selection of multiple adaptive
changes. Each pathogen has a reservoir habitat and a viru-
lence habitat. The reservoir habitat is defined as an environ-
mental site, host organism or population, or specific body
compartment where the pathogen can sustain itself and from
where it can be transmitted to other habitats or hosts. The
virulence habitat is a disease-susceptible host, or a specific
compartment within that host, in which growth of the
pathogen causes clinical infection, thereby inducing host
damage either directly, by the production of toxic com-
pounds, or indirectly, by provoking self-damaging host
responses. Host genetic factors determine differences in host
susceptibility to infection and contribute to the pattern of
clinical disease. The host’s immune response represents an
important selective force because it creates indirect compe-
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tition between pathogens by limiting the number of non-
immune or susceptible hosts. Social changes, such as those
arising through “globalization,” and climate change are
important determinants of the susceptibility to infections by
different human populations.
Section II, “Evolutionary genetics of microbial
pathogens” (chaps. 12–20). Evolution occurs through genet-
ic variation and selection and is the fundamental strategy of
life, allowing organisms to adapt to new environments and
to adverse conditions. Variation in microbial pathogenesis is
based on three mechanisms of genetic variability: point
mutation, genetic rearrangements, and lateral gene transfer.
Genomics and genome sequencing studies have corroborat-
ed that the position of genes in the chromosome (or
genophore) is not random but is a result of selection. The rel-
ative positions of genes may influence their expression,
mutational bias, and rearrangement, as well as paralogous
gene evolution and the reductive evolutionary process.
Besides its “original” set of genes, the genome of a bacteri-
um may contain other elements from other bacteria: genom-
ic islands, plasmids, and bacteriophages. 
Some virulence determinants are clustered in patho-
genicity islands acquired by horizontal gene transfer from
another, unknown bacterial species. Genomic islands are
parts of the genomes of many bacteria, pathogenic as well as
non-pathogenic, and pathogenicity islands were the first
group of genomic islands to be described. In addition, many
bacteria harbor extrachromosomal elements in the form of
plasmids that carry genes conferring a selectable phenotypic
character under specific niche conditions. Finally, bacterio-
phages (prophages), present in both pathogenic and non-
pathogenic strains, shape bacterial evolution in that they are
ideal carriers for horizontal DNA transfer. Based on our cur-
rent understanding, ~12% of the Escherichia coli chromo-
some consists of phages, with 51 different functional pro-
phages identified in 27 E. coli strains. Incorporation of exter-
nal genomic elements gives rise within a population to clones
with different pathogenicities. Such pathogenic clones are
responsible for disease outbreaks and increases in bacterial
infection frequencies. These observations have important
implications for our understanding of infectious diseases and
the public health measures required to reduce their detrimen-
tal and potentially devastating effects on society.
Section III, “Evolutionary biology of drug resistance”
(chaps. 21–28). Antibiotic resistance is not only a clinical
problem but also a unique opportunity to observe “evolution
in real time.” Antibiotic resistance may be regarded as the
paradoxical consequence of successful antibiotic therapy.
Antibiotics were initially developed for the treatment of bac-
terial infections in humans, but their miraculous effects
quickly led to their use in other animals and in plants.
Antibiotics are used both internally and externally, maintain-
ing the health of people, animals, and agricultural crops, and
have vastly changed the relationships between bacteria and
humans. Today, we are witnessing another change—in the
relationships among bacteria themselves. Almost as soon as
it was known that certain substances could kill microorgan-
isms, it was also recognized that some microorganisms
could survive normally lethal doses of these same agents.
The first clinical report of acquired resistance to an antimi-
crobial agent was published in 1937, when Crean, a naval
genitourinary specialist, reported in The Lancet that six of
100 patients with gonorrhea were unresponsive to treatment
with sulfonamides. Reports of resistance to penicillin
appeared in 1941, and to streptomycin in 1946. The term
‘‘antibiotic resistance’’ soon acquired a notorious meaning.
Traditionally, it was thought that exposure of bacteria to
antibiotics caused the selection of pre-existing resistant vari-
ants, but it seems that, under certain conditions, an antibiot-
ic may also increase the mutation rate of a bacterial popula-
tion (hypermutable strains or mutators). Mutators increase
the probability of favorable mutations and they can acceler-
ate the evolutionary rates of resistant variants that become
fixed in the population. 
Sections IV–VI, “Evolutionary pathogenicity of gram-
negative and gram-positive bacteria and of fungi (chaps.
29–49). Although a wide range of microorganism–host rela-
tionships can ultimately lead to disease, the two most gener-
al strategies used by pathogenic microorganisms are aggres-
sive “frontal” assaults and ”stealth” assaults. Typically,
frontal assault strategies require that the infecting microor-
ganism rapidly replicates, induces disease symptoms that
overwhelm the innate defenses of the host, and then find a
new host before engagement of the latter’s “adaptive”’ or
“acquired” immune system, in which antigen-specific lym-
phocytes respond to antigen exposure. These microorgan-
isms typically produce toxins or effector proteins that disrupt
the normal function of the host cell. Stealth assaults, by con-
trast, typically involve a slower infection process, in which
the microorganism subverts the host’s innate and adaptive
immune systems to set up a chronic or persistent infection.
This section of the book includes a description of the patho-
genic traits characteristic of several species of bacteria and
fungi pathogens.
A major goal of Evolutionary biology of bacterial and
fungal pathogens as a whole is to convey the idea that bac-
73INT. MICROBIOL. Vol. 11, 2008
enjoy the opportunity to learn more about the natural history
and evolution of “bad” microorganisms. As noted in the
Foreword by Julian Davies, “All microbiology is environ-
mental microbiology and has been for billions of years.”
Accordingly, pathogens can only be efficiently fought if we
employ the knowledge developed by eco-evo approaches.
Although the evolutionary origins of the relationships
between prokaryotes and eukaryotes remain to be eluci-
dated, we at least know the context in which they must be
understood. As Francis Bacon wrote in Advancement of
Learning: “If a man will begin with certainties, he shall end
in doubts; but if he will be content to begin with doubts, he





teria undertake similar forms of microbial variation in differ-
ent habitats. The main distinction is that the habitat of a “nat-
ural” microorganism is the abiotic environment, while that
of a pathogen is another living organism—the (human) host.
Pathogens, but also non-pathogenic bacteria, harbor genetic
elements that contribute to fitness adaptations in different
environments. Microbial infections of humans are a rela-
tively recent interaction, whereas the genetic and biochemi-
cal functions necessary for invasion and infection of the
“modern host” probably evolved in an ancient environment
from cell to cell interactions between microbes and protists
or small invertebrates. As such, bacterial virulence factors
have not evolved merely to cause disease in humans; rather,
they are part of a general mechanism to coexist with, to
cover, or to penetrate eukaryotic cells.
A significant and practical aspect of the book is its
Glossary, which covers most of the evolutionary microbiol-
ogy terms used in the book. Not only specialists but also
advanced students will quickly find that the book is an
essential part of any library of microbiology or related sci-
ences. Moreover, microbiologists, and not only those active
in the health sciences or field of infectious disease, will
